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Cancer beyond genetics: 
On the practical implications of downward causation 
 
Sara Green1*
 
Abstract 
Discussions about reductionism and downward causation are often assumed to be primarily of interest 
to philosophers. Often, however, the question of whether multi-scale systems can be understood 
“bottom-up” has important practical implications for scientific inquiry. Cancer research, I argue, is one 
such example. While the focus on genetic factors has intensified with recent investments in cancer 
genomics, the importance of biomechanical factors within the tumor microenvironment is increasingly 
acknowledged. I suggest that role of solid-state tissue properties in tumor progression can be 
interpreted as a form of downward causation, understood as constraining relations between tissue-scale 
and micro-scale variables. Experimental demonstrations of these sort of influences reveal limitations of 
reductionist accounts and expose the dangers of what Wimsatt calls functional localization fallacies. 
The latter relate to the common bias of downgrading factors that – as a practical necessity – are left out 
of scientific analysis. Any heuristic, experimental or theoretical, involves foregrounding some aspects 
while ignoring others, and the complexity of cancer leaves room for the co-existence of many different 
partial perspectives. These perspectives are not reducible to one another, but neither do they in this case 
make up a neatly integrated “causal mosaic” of different influences. At present, the picture of cancer 
research looks more like a fragmented cubist painting in need of a more balanced attention to 
difference-making factors at higher levels or scales.   
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1. Introduction 
Cancer is no more a disease of cells than a traffic jam is a disease of cars. A 
lifetime study of the internal combustion engine would not help anyone 
understand our traffic problems (Smithers, 1962). 
 
Debates on the characteristics of cancer are as tangled today as they were in the beginning of the 20th 
Century (Baker, 2012; Plimmer, 1903). The question about the appropriate level of analysis is perhaps 
even more pressing in an era of large-scale investments in cancer genomics. Whereas some praise the 
potentials of genomics for understanding, stratifying, and treating different cancer types, others call for 
more attention to higher-level dynamics and organization of tissues. At stake are not only theoretical 
controversies but also issues with practical implications for experimental research and therapeutic 
interventions.  
 
From a biological perspective, physics is often seen as a discipline aiming for reductionist (or 
fundamental) explanations. I challenge this view, and reductionism more generally, by focusing on the 
role of biomechanical features within the Tumor Microenvironment (TME) for cancer development 
(Laplane et al., 2018). I show how solid-state tissue properties in tumor progression supports the 
importance of macroscale features of living systems. Moreover, I suggest that biomechanical 
constraints can shed light on the controversial notion of ‘downward causation’ that is often used to 
distinguish between reductionist and anti-reductionist approaches in philosophy of biology (Campbell, 
1974; Mossio et al., 2013; Wimsatt, 1994). An examination of downward causation in the context of 
cancer is of relevance also to broader questions about the explanatory scope of genetics.  
 
Before we begin the analysis, it should be noted that “biological levels” are not unambiguously 
delineated (McGivern, 2008; Potochnik & McGill, 2012). Levels can be defined spatially, functionally, 
or temporally (DiFrisco, 2017), and the notion can be sensitive to circumstances of its use such as 
different disciplinary contexts (Brooks & Eronen, 2018; Wimsatt, 1972). In the following, I use the 
term “level” when referring explicitly to part-whole relations in organisms, such as genomes, cells, or 
tissues (see also Kaiser, 2015; Love, this issue; Wimsatt, 2007). However, the proposed view does not 
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depend on any particular specification of levels. I prefer the term scale when more broadly discussing 
the influence of macroscale features, which also has implications for physics (Batterman, 2012).  
 
I begin with some background for the discussion of whether a gene-centric view on cancer is adequate 
(Sections 2 and 3). I then examine studies emphasizing the importance of macroscale biophysical 
features of the TME (Section 4). I argue that influences of physical features such as matrix stiffness can 
be interpreted as a form of downward causation, understood as constraining relations that can be 
mathematically interpreted as boundary conditions (Section 5). Sections 6 and 7 discuss implications 
for philosophical debates on reductionism and reflect on the possibility of a unified multi-scale 
approach to cancer. Section 8 offers a summary concluding remarks.  
 
2. Background for the debate 
 
The dominant view of cancer presented in almost all cancer biology textbooks is that carcinogenesis is 
driven by genetic instability in terms of somatic mutations that alter cell signaling pathways. 
Historically, this view has been called the Somatic Mutation Theory (Vaux, 2011) or the oncogene 
paradigm (Plutynski, 2018b). Cancer researchers today recognize that multiple factors influence the 
proliferation of cancer cells (Weinberg, 2007; Hanahan & Weinberg, 2011), but most research efforts 
still focus on genetic factors and molecular pathways as targets of intervention and explanation. 
Recently, investigation of genetic factors has intensified through large-scale projects such as The 
Cancer Genome Atlas (TCGA, 2005-2016), which utilized automated sequencing tools and algorithms 
to identify genetic variants associated with different tumor types. Identification of cancer biomarkers 
are not only expected to increase our understanding of the diversity of cancer types but also to allow for 
personalized therapies (Tomczak et al., 2015). 
 
In contrast to the optimism concerning new potentials of cancer genomics, some see investments in 
large-scale genome projects as “one more misstep in the war on cancer” (Miklos, 2005). Despite 
decades of heavy investment in research on genetic markers and molecular pathways involved in 
cancer development, results in terms of improved understanding and clinical control have so far been 
disappointing (Lazebnik, 2002; 2010; Prasad et al., 2016). Some have questioned whether “cancer 
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cells”, understood as entities with distinct molecular properties, can be meaningfully delineated at all 
(Soto & Sonnenschein, 2011). The skepticism is motivated by a set of difficulties in distinguishing 
between mutational signatures in healthy and ‘cancerous’ cells, and between malignant and benign 
tumors (Baker, 2013; Hanahan & Weinberg, 2011). Accordingly, some have argued that cancer is a 
disease that has to be characterized at higher scales or levels.  
 
The importance of higher-level features for understanding cancer has been taken up by other 
philosophers, specifically in discussions of the Tissue Organization Field Theory (TOFT) 
(Sonnenschein & Soto, 1999; 2011). This approach characterizes cancer as a failure of tissue 
organization. Philosophical debates have centered on the extent to which the frameworks of SMT and 
TOFT can be combined (Bedessem & Ruphy, 2015; 2017), or whether these are theoretically 
incompatible due to conflicting ontological assumptions (Baker, 2013; Bizzarri & Cucina, 2016; 
Montévil & Pocheville, 2017). The debate provides intriguing insights into the implications of different 
ontological assumptions for our understanding of cancer. However, since the SMT and TOFT can be 
viewed as two extremes in a continuum of approaches to cancer, I shall focus more broadly on the role 
of the TME (see also Plutynski, 2018a).  
 
The TME concept can encompass different experimental and theoretical approaches to cancer that go 
beyond TOFT (Laplane et al., 2018). The TME concept also has a long and diverse history, as it has 
been highlighted by immunologists and researchers focusing on angiogenesis since the 1970s (e.g., 
Folkman, 1971; Witz 2009).2 Central to emphasis on the TME is, however, that the environment of the 
tumor cells influences or constrains the possibilities of cell growth and proliferation. Similar insights 
have been stressed by developmental biologists that have experimentally demonstrated the influence of 
properties of the extracellular matrix (ECM) on development of breast cancer (Lochter & Bissell, 
1995). The framework of TME allows researchers to acknowledge top-down influences without 
denying the importance of genetic causation (Malaterre, 2011). Yet, as we shall see in the following, 
research on the role of the TME does challenge the explanatory scope of genetic approaches to cancer. 
                                               
2 Angiogenesis is a physiological process where new blood vessels are formed through branching from pre-existing vessels. 
Blood supply is often a bottleneck in tumor development and angiogenesis has recently become a target in cancer 
treatments.  
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3. Postgenomic puzzles and recombination experiments 
 
The call for a higher-level perspective on cancer has a long history in biology but is currently also 
motivated by what Baker (2013) calls “postgenomic puzzles”. The term refers to results of tumor 
sequencing that reveal unexpected complexity.  
 
Efforts to understand cancer in terms of molecular mechanisms have been motivated by successful 
identification of genetic difference-makers from the 1970s and onwards. Examples are the tumor 
suppressor gene P53 and BRCA-markers used in risk analysis for breast cancer. Technologies such as 
Genome-Wide Association Studies have further resulted in the identification of a vast number of 
genetic factors and molecular pathways associated with cancer development. The genetic heterogeneity 
of tumors may even be so vast that each cancer is different. A widely cited quote from the US National 
Institute of Health with the launching of TCGA reads as follows:  
 
Cancer is a disease of the genome and as more is learned about cancer tumors, the more we are 
finding that each tumor has its own set of genetic changes. Understanding the genetic changes 
that are in cancer cells is leading to more effective treatment strategies that are tailored to the 
genetic profile of each patient's cancer.3 
 
While such quotes frame tumor heterogeneity is as a potential for individualize treatments, others 
interpret such discoveries as a severe challenge to the idea of associating cancer types with stable 
genetic markers.  
 
Many tumors have been found to have heterogeneous mutational patterns. A few mutations are highly 
frequent in many cancer types, but a long tail (graphically speaking) of diverse mutations have been 
discovered both between and within tumors. Mutational signatures have been found to vary when 
biopsies are taken at different spatial locations in the tumor or within the same location over time 
                                               
3 The Cancer Genome Atlas Program: https://cancergenome.nih.gov/cancergenomics/impact, accessed 30/7-2018. 
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(Blanchard & Strand, 2017). Even more puzzling is that some tumors have normal mutation rates 
(Greenman et al., 2007; Qiu et al., 2008), and many cells with genetic lesions do not develop into 
tumors (Bissel & Hines, 2011). Such results have engendered skepticism about whether cancer 
development can be captured in simple mechanistic models at the scale of genetic or molecular 
interactions. Similar cancer phenotypes can be realized through multiple genetic and molecular 
pathways, suggesting that it may be useful to search for higher-scale influences that bring clarity to the 
diverse influences.  
 
Stromal components such as fibroblasts, immune cells, and the extracellular matrix, can make up to 
80% of a tumor (Plutynski, 2018a, p. 25). Whereas much genetic research has focused on molecular 
changes within epithelial cells and their resulting behavior, the following shows how recombination 
experiments shift the focus to the structural role of connective tissues. In recombination experiments, 
cells are transplanted to new host organisms (or new TMEs). Recombination experiments allow for 
observation of the effects of cell development in response to experimental interventions where 
epithelial cells or the surrounding tissue are exposed to a carcinogen. Such experiments draw attention 
to how philosophers should not only pay attention to how scientists represent levels, but also how they 
manipulate or intervene on them (see also Love, this issue; Woodward, this issue).  
 
Recombination experiments conducted in already in the 1950s suggested that carcinogen-induced 
“cancer cells” can be normalized if transplanted into normal tissue.4 Similarly, neoplastic induction was 
observed when normal cells were inserted in carcinogenous tissue. From the 1980s, systematic 
experiments were conducted of how features at different scales influenced development and 
carcinogenesis. As a consequence, Bissell and colleagues challenged the view that intercellular 
structures merely constituted “passive conditions” or “housekeeping functions” for the maintenance of 
cells (Plutynski, 2018b).  
 
Bissell’s group showed that tissue-specific traits of relevance to the development of cancer were often 
lost in 2D cultures (petri dishes with a single layer of cells). For instance, experiments demonstrated 
                                               
4 For a comprehensive review of important experiments, see (Baker, 2012; Bizzarri & Cucina, 2014). 
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that the fate of cells with virus-activated oncogenes depended on whether the cells were cultured in a 
petri dish or left in a chick embryo (Dolberg & Bissell, 1984; Stoker et al., 1990). If the cells were 
removed from the embryo and cultured in a petri dish, they displayed the transformed phenotype within 
less than a day. However, if left in the embryo, the cells developed normally until much later. This 
suggests that the host environment plays an important role in buffering or dampening the effects of 
genetic lesions. More generally, the results suggest that the features of cancer cells are highly 
dependent on a context of reciprocal interactions with the microenvironment (see also Nelson & 
Bissell, 2005; 2006).  
 
Other historically important experiments were conducted by Ana Soto, Carlos Sonnenschein, and 
colleagues. They transplanted tumor cells from a donor mouse to normal tissue in mice hosts of 
different ages and hormonal stages (Maffini et al., 2005). If genetic instructions determined cell 
growth, one would expect the hosts to develop the same rate of tumors. Instead, they observed that 
tumor incidence varied among the hosts, and that in some cases no tumors formed at all. Similarly, 
from a reductionist perspective, replacement of healthy fat pads with pre-cultured tumor cells would be 
expected to result in tumor development. Yet, they observed normal development of tissue structures in 
all hosts. These experiments support the view that neoplastic cells can be normalized, depending on 
environmental conditions.  
 
The cellular environment can also direct cell fates in the opposite direction: normal cells can undergo 
neoplastic induction if they are transplanted to tissue environments with carcinoma-exposed stroma. 
Maffini et al. (2004) investigated whether cancer originates in the stroma tissue or (bottom-up) with 
genetic mutations in epithelial cells. They surgically separated the stroma and epithelium such that each 
of these could be exposed to a chemical carcinogen. Interestingly, they observed that neoplastic 
transformation occurs only when the stroma had been exposed to the carcinogen. Similar results have 
been obtained also in experiments investigating tumor development around kidneys (Barclay et al., 
2005). Additionally, studies within developmental biology show that the biomechanical context of the 
stroma can play essential roles in directing the development of the mammary gland and also influence 
the response to oncogenic mutations (Nelson & Bissell, 2006). 
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The ability of cancer cells to adapt or reprogram their expression profiles in response to their 
environment suggests that influences from the microenvironment in some cases can overrule genetic 
“instructions” and direct cell fate. The following sections examine how this has important practical as 
well as philosophical implications.  
 
4.  Beyond the level of single cells: The Tumor Microenvironment  
 
In a widely cited Nature review, Bissell and Hines (2011) ask “Why don’t we get more cancer?”. The 
question is spurred by the observation that there are far fewer incidents of cancer than we should expect 
from the number of harmful mutations identified in cancer genomics. This has important implications 
for understanding the problem of overdiagnosis in cancer, i.e., for making sense of why some genetic 
or cellular abnormalities do not develop into symptomatically manifest disease (Green & Vogt, 2016). 
A perspective beyond genetic is therefore needed to better understand the context of cancer 
development, including how higher-scale physical cues influence hierarchical control of cell 
proliferation.  
 
Novel technologies to experimentally measure and manipulate physical cues have increased the ability 
of researchers to identify the effects of tissue stiffness. For instance, the development of 3D laminin 
rich gels to simulate the TME has allowed for systematic studies of the plasticity of cell populations 
that enable tumor cell reversion, depending on microenvironmental signals and tissue architecture 
(Nelson and Bissell 2005; 2006). A highly cited study by Paszek and colleagues (2005) illustrates this 
approach. The group used an electromechanical indentor to measure the relations between matrix 
stiffness and tumor development among colonies of mammary epithelial cells (MECs). The first step of 
the analysis compared normal breast tissues to malignant tissues in transgenic mice. The analysis 
showed that an average tumor, and stroma attached to tumors, are much stiffer on average (4049 Pa ± 
938) compared to a normal mammary gland (167 Pa ± 31).  
 
To test whether stiff stroma was induced by genetic lesions, or whether the influence could go also in 
the opposite direction, Paszek et al. cultured normal MECs on gels with varying rigidity. They found 
that increased matrix stiffness significantly perturbed the tissue architecture (Figure 1). 
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Figure 1. Phase contrast microscopy (top row) and confocal IF images of mammary epithelium cell cultures on gels of 
varying stiffness, represented as increasing values for elastic modulus (a measure of how much a material will elastically 
deform when subjected to stress). The images show the colony morphology after 20 days. Nuclei were stained with DAPI 
(blue coloring). The two bottom rows show cultures grown on collagen gels and basement membrane (BM) gels, 
respectively, using different staining techniques. The arrows highlight how increasing matrix stiffness (left to right) leads to 
destabilization of adherence junctions (green staining for b-catenin) and adhesion of integrins (red staining). Figure 
reprinted from (Paszek et al., 2005), with permission from Elsevier. A color version of the figure can be found in the online 
version of this chapter or in (Paszek et al. 2005, Figure 2C).  
 
The experiment by Paszek et al. (2005) suggested that increased matrix stiffness destabilizes adhesion 
of cell junctions and integrins. Integrins are transmembrane ECM receptors that function as force-
sensitive mechano-transducers by triggering cellular pathways. Accordingly, the group hypothesized 
that integrin alteration could lead to altered activity of proteins involved in growth-related molecular 
pathways. The study confirmed that cells with the malignant phenotype have higher activities of the G-
protein Rho and associated kinases (ROCK and MLC in Figure 2).  
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Figure 2 highlights how integrin activation can trigger other molecular pathways stimulating cell 
proliferation, generating feedback that results in further stiffening of the matrix. The distinction 
between a “soluble” and “solid-state” signaling pathway emphasizes how studies of biochemical 
signaling pathways and of physical properties of the matrix, respectively, are considered equally 
important (Huang & Ingber, 2005).  
 
 
 
 
 
 
 
 
 
 
Figure 2. A mechanical autocrine loop that illustrates 
how ECM stiffening can lead to cancer development 
through a cascade of processes that further increases 
matrix rigidity. Reprinted from (Huang & Ingber, 
2005) with permission from Elsevier.  
 
The recombination experiments discussed in Section 3 showed that transplantation of malignant cells to 
normal tissues can normalize cell-growth, and vice versa. Similarly, Paszek et al. (2005) demonstrated 
that the malignant phenotype can be strengthened or reverted, depending on the stiffness of the 
substrate. Approaches drawing the framework of condensed matter physics have more recently 
revealed that increased matrix stiffness correlates strongly with the development of breast cancer (Boyd 
et al., 2007), and that fluid and solid stresses influence the invasive potential of tumor cells (Rankin & 
Frankel, 2017; West et al., 2017) as well as treatment response (Stylianopoulus 2017). Taken together, 
the results suggest an interpretation of the TME as a double-edged sword that can either protect from or 
promote cancer, depending its physical properties (Bissell & Hines, 2011).5   
                                               
5 For other studies appealing to factors beyond genetic instability, see (Baker, 2013; Bizzarri & Cucina, 2014; Egeblad et 
al., 2010; Laplane et al. 2018; Soto & Sonnenschein, 2011). 
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It has recently been suggested that the physical properties of the TME offer new potential targets for 
cancer treatments (Bissell & Hines, 2011; Rankin & Frankel, 2016; Hirata & Sahai, 2017; 
Stylianopoulus, 2017). Following an initiative by the US National Cancer Institute in the late 1980s, 
antitumor drug screening is often carried out in 2D cultures. Yet, as highlighted in Section 3, the fate of 
cancer cells in response to carcinogenic or anti-carcinogenic influences may differ, depending on 
whether the cells are cultured in a petri dish or within the environmental context of the host organism. 
An important clinical implication of the experimental limitations of 2D cultures is that these cannot 
account for the development of drug resistance, which is very common in in vivo tumors. Limitations 
of 2D cultures has been suggested as part of the translational challenge that only 1-2 per 10.000 
candidate drugs from antitumor drug screening currently make it further than Phase III studies (Feng et 
al., 2013).  
 
In contrast, 3D cultures that can better account for the influence of biomechanical constraints on drug 
response (Nelson & Bissell, 2006; Soto et al., 2008). For instance, the response of breast cancer cell 
lines to two antitumor drugs, cisplatin and taxol, has been demonstrated to depend on substrate stiffness 
(Feng et al., 2013). Recently, 3D hyaluronan gels have been used to mimic the tumor ECM in cell 
invasion studies. This line of research is inspired by the discovery that the physical properties of 
stromal components of cancer-resistant naked mole rats differ compared to humans (reviewed in 
Rankin & Frankel, 2016). One of the important components of the microenvironment is hyaluronan, a 
glycosaminoglycan that can form gel like structures influencing the density and fluid pressure of the 
ECM. Chemical modifications of hyaluronan could potentially allow for interventions on the physical 
properties of the ECM and subsequently affect cell proliferation and cell invasion. Elevated solid stress 
has also been shown to create a fluid flux from tumors to surrounding tissues, and stress-alleviating  
stragies have been proposed as a way to improve treatment response (Stylianopoulus, 2017)  
 
Compared to 2D cultures, 3D cultures are more demanding in terms of experimental resources and 
have other limitations (see Section 6). Yet, as argued in the following, they uncover aspects of cancer 
that may be interpreted as a form of downward causation.   
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5. Downward causation 
 
How can we make sense of the role of tissue-scale biomechanical factors in the context of cancer? I 
suggest that the role of tissue-scale biomechanics can be interpreted as an instance of downward 
causation. Importantly, however, the account defended is different from the “strong” account criticized 
by Kim (1998) and others, which entails synchronic efficient causation across levels and ontological 
autonomy of higher-level wholes of lower-level parts. Instead, I consider downward causation as a 
relation between system variables operating at different scales. This suggestion is in line with 
Woodward’s account (this volume) that highlights effects on lower-level variables through 
manipulation of high level variables as the criteria for downward causation (see also Ellis, 2012). The 
experiments presented in Sections 3 and 4 are examples of interventions on higher-scale factors (tissue 
stiffness) that influence the behavior of lower-scale variables (gene expression and cellular behaviors) 
and thus satisfy this criterion.  
 
Top-down influences, in my view, are best understood as constraining relations that “select and delimit 
various types of the system’s possible developments” (Emmeche et al., 2000, p. 25; see also Brooks & 
Eronen, 2018). This account is also inspired by systems biologist Denis Noble’s suggestion that 
downward causation can be interpreted mathematically “as the influences of initial and boundary 
conditions on the solutions of the differential questions used to represent the lower level processes” 
(Noble 2012, p. 55; see also Ellis, 2012). The account is developed in more detail in a separate paper 
on downward causation in the context of multi-scale cardiac modeling (Green, 2018).6 Here, I 
primarily wish to defend the explanatory importance of higher-level constraints.   
 
By constraints, I understand features that delimit the degree of freedom for a given (Hooker, 2013; 
Umerez & Mossio, 2013). Constraints not only limit possibilities through restraints on the possible 
system states but also enable certain states that would be impossible to reach for the unconstrained 
system. For instance, Noble highlights that the oscillating dynamics of the heart rhythm cannot be 
                                               
6 As discussed by Mark Eronen at the meeting at the KLI, it can be debated whether one should insist on the term downward 
causation on this basis. I have no strong stance on this, but I hope to show that interpreting downward causation through 
constraining relations does not weaken the causal and explanatory power of top-down effects (Ellis 2012).  
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generated (or explained) without the boundary of cell structure, which creates a concentration gradient 
(cell voltage or cell potential) across the cell membrane. He argues that “without the downward 
causation from the cell potential, there is no rhythm” (Noble, 2012, p. 58).  
 
Physical constraints are often mathematically represented as boundary conditions that impose limits on 
the domain of the model. These typically cannot be defined at the lowest explanatory scale. For 
instance, in Noble’s example of the heart rhythm, the cell potential is a variable that cannot be 
understood or measured at the genetic level. It is a parameter that has to be measured at a higher scale 
(e.g., through microelectrode measurements of intact or coupled cells). Without imposing boundary 
conditions on the solutions of lower-scale models (in this context ordinary differential equations), the 
lower-scale models cannot be solved. Medium downward causation thus reveals important limitations 
to a reductionist perspective – by demonstrating the explanatory limitations of microscale details even 
for models at the lowest scale. 
 
The requirement of higher scale parameters is not unique to biology. Macro-scale parameters are also 
indispensable when modeling physical behaviors, such as steady state heat conduction in a rod 
(McGivern, 2008) or drop-formation (Batterman, 2006; for other examples see Batterman, 2012; 2018). 
In the context of multi-scale cancer models, an important macro-scale parameter is matrix stiffness, 
defined as Young’s modulus (also called the elastic modulus), which outlines how much a material will 
deform in response to stress as a property evenly distributed over a given material’s surface (Deisboeck 
& Stamatakos, 2011). The stiffness of a material, whether the material is steel or biological tissues, is a 
macro-scale parameter that identifies elastic properties by treating structure as a larger continuum of 
matter (Green & Batterman, 2017). In our examples here, matrix stiffness is inherently a tissue-scale 
parameter because it depicts the physical forces acting on the integrated effects of cell populations that 
are constrained by certain geometrical structures (Davidson, von Dassow, & Zhou, 2009). Other 
examples of macroscale parameters used in continuum models of tumor dynamics are forces of cell-cell 
adhesion, migration velocity of cells, ECM fiber thickness and length variation (Deisboeck & 
Stamatakos, 2011; West et al., 2017). Whenever the output of models or experiments targeting lower 
scales (e.g., gene regulatory networks) is influenced by changes in high level variables such as tissue 
stiffness, I would argue that we have an instance of “downward” regulation of cell behavior.  
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The need for multiple approaches not only results from the complexity of biological systems but also 
from what, in the context of physics, has been called the “tyranny of scales” (Oden, 2006). The 
problem refers to the scale-dependency of physical properties as well as the conceptual frameworks we 
understand these through. Batterman (2012) highlights that when modeling physical systems, such as a 
steel beam, it is not possible to describe all relevant factors in one overarching mathematical 
framework. Steel exhibits different physical properties at the atomic, intermediate, and macroscales, 
and capturing all aspects requires that different models are employed. For instance, continuum models 
describing elastic macroscale properties of steel treat the material as a continuum without discrete 
structures. But an examination of the structure of steel at a mesoscale reveals grain boundaries, cracks 
etc. Because physical behaviors and our concepts used to describe these are “multi-valued” across 
scales (Wilson, 2012), researchers are inevitably forced to combine different mathematical frameworks 
to account for structures and processes across scales. 
 
The situation is analogous in the context of cancer. Young’s modulus is a continuum parameter that 
treats materials as if they were continuous rather than made up discrete parts. Obviously, biological 
systems consist of very different parts with different properties, and such crude idealizations may seem 
misguided. But a striking insight is that coarse-grained models often work well, despite of (and often 
because of) such simplifications (Batterman, 2018). Continuum models necessarily abstract from 
lower-scale details to identify parameters operating at higher scales. Importantly, and as further 
defended below, matrix stiffness cannot be understood simply as the aggregated effects of molecular 
actions (see also Batterman & Green, forthcoming). Relative autonomy of scales or levels is thus one of 
the key factors in support of downward causation. In the following, I consider and reply to potential 
objections to this point.  
 
6. Potential objections and replies 
 
A reductionist could object that since a tumor consists of nothing but molecular constituents, a more 
fundamental model targeting lower scales should in principle be sufficient. Such “in principle 
arguments” are, however, not particularly convincing or interesting if they are not accompanied by a 
clarification of how one would conduct such a reduction in practice (see also Batterman, 2018). 
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Particulalry, the reductionist has to clarify how upper-level variables are supposed to be reduced to 
lower-level variables.  
 
One problem for the reduction of upper-level variables is multiple realizability, i.e., that a given upper-
level variable has a number of different lower-level “realizers” (Woodward, this issue). An important 
consequence of multiple realizability is that much of the variation at a micro level does not matter for 
the study of macroscale properties. Woodward refers to such cases as instances of conditional 
independence. In the context of cancer research, the dynamic state of given cancer phenotype may be 
realized by multiple molecular states, and biochemical details do not always matter for prediction of the 
tissue-scale effects (West et al., 2017). The reductionist thus has to explain how it is possible to have 
this sort of explanatory autonomy (Batterman, 2018).7  
 
Another important problem for the reductionist is that many higher-level variables are irreducible in the 
sense that they cannot be measured or conceptualized at lower scales (Ellis, 2012). I began the paper 
with a quote from Smithers (1962) arguing that cancer is no more a disease of cells than a traffic jam is 
a disease of cars. In both contexts, studying the constituents of the individual components, cars or cells, 
would not allow us to explain why the problem of cancer or traffic jams arise. Both are macroscale 
phenomena that we make sense of by looking at higher-level relations between the constituents, 
involving structural constraints such as roads and tissue boundaries. The examples are analogous to 
how the rules of a competitive sports game cannot be derived from detailed studies of the behavior of 
individuals (Sawyer, 2002), or how properties such as the temperature or pressure of a gas cannot be 
ascribed to individual gas molecules (Christiansen, 2000). The reductionist therefore has to clarify how 
we can make sense of such macroscale phenomena without reference to higher-level concepts and 
parameters.  
 
                                               
7 As highlighted by Woodward, multiple realizability need not make higher-level explanations inferior, since explanatory 
relevance is dependent on epistemic aims that define the criteria for conditional relevance or irrelevance. Moreover, as 
illustrated by Figure 2, one often needs to account for multiple causal factors operating in what Woodward calls causal 
cycles (i.e., where influences go in both directions). But it does present a challenge for the view that features at the lowest 
scale are sufficient.  
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One strategy to respond to such examples in support of a reductionist view is to say that although 
constraints from higher-scale structures play some causally relevant role, it does not automatically 
grant top-down effects an explanatory role in science. A perspective giving explanatory priority to 
molecular mechanisms might, for instance, interpret the result of the experiments by Paszek et al. 
(2005) differently. It might be argued that the physical forces of tissue structures are just background 
conditions for the most important difference-makers, namely the effects of increased Rho-activity on 
molecular pathways of cell cycle progression.8 
 
Privileging genetic causation is motivated by an epistemic ideal in biology that emphasize cell-
autonomous or “instructive” molecular information. In cancer research this ideal is reflected in the 
prioritization of “intrinsic” factors of carcinogenesis. Whereas this ideal has its merits for answering 
some explanatory questions, it may be counterproductive for addressing clinically relevant aspects of 
cancer. Methodological reduction, i.e., strategies to ignore or simplify some aspects in order to focus on 
others, is a necessary requirement for any scientific analysis of complex systems (Wimsatt, 2007). But 
if one is unaware of the existence of blind spots created through specific theoretical and experimental 
choices, there is a risk of committing what Wimsatt at the KLI-meeting called functional localization 
fallacies. The term refers the common bias of downgrading factors that – as a practical necessity – are 
left out of scientific analysis. The rejection of the explanatory role of tissue biomechanics may partly 
result from a functional localization fallacy.  
 
Biomechanical factors are often ignored or held fixed as a practical requirement for experimental 
intervention on genetic factors (Robert, 2004). Hence, the results of such experiments cannot be 
informative of the relative importance or (ir)relevance of biomechanical factors as these are excluded 
from the outset of the analysis. As mentioned, genetic difference-making is often studied through 2D 
cultures of cell populations with controlled and modified gene expression, e.g., via gene knock-out 
experiments (Vaux, 2011). Such studies, together with more recent tumor sequencing projects, have no 
doubt shed light on important genetic markers and pathways involved in carcinogenesis. But as it is 
now well established that epithelial cells behave differently if placed in a dish coated with basement 
                                               
8 Such an argument has been put forward in philosophical discussions about reductionism, e.g., by pointing out that 
macroscale features are merely background factors in molecular developmental biology (Rosenberg, 1997).  
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membrane proteins or in cultures mimicking the TME rather than cultured on a plain plastic dish 
(Plutynski 2018a, p. 41; 2018b), reference to the success of the gene-centric line of research cannot 
support the rejection of an explanatory role of physical features of the TME. Traditional gene-centric 
experimental designs are thus inherently limited when it comes to accounting for the role of macroscale 
physical factors in the natural environment of the cells (Soto & Sonnenschein, 2011; see Brigandt & 
Love, 2017 for a more general discussion of reductionism in biology).   
 
As mentioned in Section 4, alternative attempts involve building higher-dimensional models, such as a 
3D model of the mammary gland and hyaluronan gels to mimic the TME (Nelson & Bissell, 2005; 
Rankin & Frankel, 2016). Moving to the tissue scale, however, typically requires that many molecular 
details are ignored, and the experiments are more laborious and difficult to automate. They would also 
become practically intractable for studying the effects, and combined effects, of hundreds or even 
thousands of genetic difference makers. The key point is here that different experimental strategies 
foreground specific (and often complementary) aspects of a complex system, here ranging from the 
influence of biomechanical cues on cell differentiation to genetic difference making.  
 
Cancer is characterized by what Wimsatt (1972) calls interactional complexity. Although different 
experimental and theoretical approaches are compatible, different ways of investigating the system 
often require distinct ways of demarcating and decomposing the phenomenon (Plutynski, 2018a). As a 
result, the different perspectives are not straightforwardly integrated. When Huang and Ingber 
distinguish between two forms of signaling (Figure 2), it is because they wish to highlight that the 
physics perspective is not reducible to a biological  perspective, or vice versa. Whereas some would see 
the biomechanical constraints merely as background conditions, they emphasize that Paszek’s 
interventions demonstrate the causal relevance of a “physical cue devoid of chemical specificity” 
(Huang & Ingber, 2005, p. 176).  
 
The studies examined put forward the possibility that the architecture and mechanical properties of the 
tissues can be dominant over genotype, because malignant phenotypes can sometimes be reverted 
through interventions that alter microenvironmental factors (Nelson and Bissel, 2006; Paszek et al., 
2005; Bissell & Hines, 2011). This suggests that physical factors of the TME cannot generally be 
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considered merely as background conditions of limited explanatory and predictive value. A similar 
argument has been defended in the contexts of multi-scale modeling in developmental biology (Green 
& Batterman, 2017) and cardiac models systems biology (Green, 2018).  
 
Multi-scale models combine different models targeting different scales. These models are at the same 
time “explanatorily independent” and “epistemologically interdependent” (Potochnik, 2009). They are 
explanatorily independent in the sense that they legitimately ignore some aspects to address questions 
or properties at specific scales or levels. For instance, macroscale models are autonomous in the sense 
that they are often not improved by incorporation of all possible molecular details (Batterman, 2018). 
Similarly, microscale models typically black box many higher-scale features as these (autonomously) 
describe a process from a micro-level perspective.  
 
At the same time, models targeting different scales in a multi-scale modeling approach can be said to 
be “epistemologically interdependent”, because they often rely on sources of information provided by 
other sources or models (Potochnik, 2009). A model at a characteristic scale often needs inputs or 
boundary conditions defined by models of a different spatial (or temporal) scale (Lesne, 2013). In 
cancer research, multi-scale models must integrate continuum and discrete models to capture both 
large-scale volumetric tumor growth dynamics and behaviors of individual and heterogeneous cells 
(Deisboeck & Stamatakos, 2011). Because each framework presents a simplified picture of a system’s 
dynamics, their applicability may depend upon factors that the models themselves do not represent or 
capture. Lower-scale models often require macroscale inputs and vice versa, and each perspective 
foregrounds some aspects while ignoring or idealizing others.  
 
As a consequence of the tyranny of scales problem and interactional complexity, it seems futile to look 
for the origin of cancer or to debate what constitutes a “right level” of analysis. Different perspectives, 
addressing different scales using methods from different disciplines, can answer different types of 
explanatory questions. Each model addressing specific aspects at a given spatial (or temporal) scale 
will black box other questions or aspects at different scales. But if one is not aware of such “black 
boxing procedures”, it may result in theoretical biases. It could be argued that the current privileging of 
genetic factors is an example of such a bias, and that a more balanced view is needed.  
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7. Towards a multi-scale perspective on cancer? 
 
Debates on cancer are often framed as a choice between alternatives, i.e., between views of cancer as a 
genetic or tissue-based disease. However, the concept of the TME can encompass several types of 
influences on cell differentiation, spanning from biochemical influences from the surrounding cells to 
mechanical and field forces (stiffness and surface tension) and topological geometry of the tissue 
(Bizzarri & Cucina, 2014; Laplane et al., 2018). Thus, an understanding of cancer across scales need 
not privilege any one level of causation (Bertolaso, 2011; Malaterre, 2011).  
 
My aim in this chapter has not been to reject the merits of reductionist approaches. Not all explanatory 
questions require higher-level analysis, and gene-centric approaches have brought about many 
important insights to the development and treatment of cancer. Yet, the predictive capacities for clinical 
applications often depend on the willingness to embrace complexity. In other words, interactional 
complexity also has practical implications for how many theoretical perspectives are required to predict 
or explain the behavior of the system (Wimsatt, 1972; Plutynski, 2018a). Accepting a pluralistic stance 
should therefore not bar us from questioning the scope or sufficiency of the dominant gene-centric 
approach. 
 
A consequence of specialization and complexity in science is often that narrow explanatory questions 
are pursued in different settings, with limited attempts to integrate the various research results. 
Thousands of papers are published each year on cancer, many with a focus on how specific genes or 
proteins contribute to a specific cancer-related pathway. But it has proven tremendously challenging to 
synthesize insights from these studies into clinically relevant applications (Lazebnik, 2002; 2010; 
Prasad et al., 2016). Accordingly, the debate on the relevant theoretical perspectives on cancer is not 
only philosophically interesting but is also of practical importance to the design of experiments and 
prospects of funding strategies. As stated by one of key pioneers of the research program focused on 
the TME:  
 
One of the first steps in our attempts to comprehend the big picture of tumor progression is to 
realize that single molecules or single signaling pathways are just solitary components of an 
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immense network. This realization should lead to the abandonment of reductionism (which, I 
am afraid, is a difficult mission under the present culture of conducting science and its funding), 
and to the employment of approaches used in Systems Biology” (Witz, 2009, S13) 
 
Similarly, Bizarri and Cucina (2014) highlight that the pharmaceutical industry, focused on the 
development of drugs targeting specific molecular components, is strengthening the bottom-up 
reductionist approach at the expense of other potentially useful approaches. Explanatory priorities 
regarding specific levels of analysis are therefore also related to the problem of opportunity cost, i.e. to 
the problem of how to prioritize investments in different solution strategies. An important job for 
philosophy of science could thus be to examine the merits of assumptions underlying such 
prioritizations of specific levels of analysis. Another could be to examine the potial or relevance of 
integrating different perspectives. Given the complexity of cancer, it cannot be assumed that the 
development of multi-scale models will easily solve the translation problem.  
 
Multi-scale modeling is particularly challenging in biology, compared to modeling of many physical 
systems, because there are complex non-linear feedback relations that crosscut spatial and temporal 
scales. Moreover, biological systems have active boundaries that change over time as an organism 
responds to environmental stimuli, develops, and ages. This means that the causal effects of any type of 
difference-maker may be highly context-sensitive. In the context of cancer, a given genetic instability 
may for instance have very different effects depending on the age stage of a person as ageing involves 
changes in stiffness and elasticity of tissues (Bissell & Hines, 2011). Cancer is a “fast moving target” 
that develops from a variety of causes, in a variety of ways, and at various levels (Bertolaso, 2011), and 
is hence especially challenging to model.  
 
8. Summary and concluding remarks 
 
Theoretical assumptions concerning the causal nature of cancer can influence choices of experimental 
designs to study cancer – and vice versa. Functional localization of specific features of complex 
systems necessarily foreground some aspects while backgrounding others. In cancer research, 2D 
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cultures are efficient tools for studying effects of gene knockout and other molecular manipulations on 
cell proliferation. Yet, this approach is fundamentally limited in revealing environmental influences on 
tumor progression and drug response. Recombination experiments in vivo and studies of 3D cultures in 
vitro a have led to important theoretical insights as well as to suggestions of new types of cancer 
treatment. Each framework is, however, only partial. Although they can be considered explanatorily 
independent, i.e., merited by particular questions of analysis, they may be considered epistemically 
interdependent in the sense that improving predictions of one model may rely on inputs from other 
models or other experimental sources. 
 
This chapter has focused on the role of biomechanical features of the TME for cancer progression.   
I believe that the cases presented provide an interesting set of examples for philosophical discussions 
on the explanatory role and autonomy of macroscale features, as well as for discussions on the relative 
importance of biological and physical science approaches to cancer (see also Love et al., 2017). 
Contrary to the so-called layer-cake model of science, physical science approaches do not always play 
a theory-reducing role. On the contrary, in this context physical science approaches highlight the 
importance of macroscale properties. I have argued that the influence of tissue-scale biomechanical 
constraints on gene expression and direction of cell fate can be interpreted as a form of downward 
causation. Specifically, I have defended an account of downward causation that can be mathematically 
interpreted as the influences of boundary conditions on the solutions of lower-scale models.  
 
As a consequence of the interactional complexity of cancer, the results of the many efforts may not 
make up a neatly integrated causal mosaic of various factors (Love, 2017). The resulting picture may 
be more akin to a fragmented cubist painting where some aspects of the system are yet to become fully 
visible for scientific analysis.9 While this may be seen as a disappointing conclusion, it does not mean 
that improvements cannot be reached. Multi-scale approaches to cancer call for caution against the 
stubbornly persistent idea that genetic mutations constitute the most relevant or most reliable feature of 
                                               
9 I would like to thank Leen de Vreese for suggesting the analogy of a cubist painting, inspired by the work of Caterina 
Marchionni, University of Helsinki. 
 
Final draft of a chapter to be published in D. S. Brooks, J. DiFrisco & W. C.  Wimsatt (Eds.), Biological Levels: 
Composition, Scale and Evolution in Complex Systems. MIT Press. 
 
 
 22 
cancer. A perspective from higher-scale tissue biomechanics allows for other visible patterns to 
materialize, which is not only theoretically intriguing but also of clinical relevance.  
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